UNIGE document Scientific Article
previous document  unige:115852  next document
add to browser collection
Title

Modelling the Impact and Cost-Effectiveness of Extended Screening and Treatment with Direct-Acting Antivirals in a Swiss Custodial Setting
Authors
Girardin, François
Hearmon, Natalie
Castro, Erika
Negro, Francesco
Eddowes, Lucy
Getaz, Laurent
Wolff, Hans
Published in Clinical Infectious Diseases. 2019
Abstract Hepatitis C virus (HCV) amongst people living in detention (PLD) is typically high in many countries including Switzerland, where it is estimated that the HCV prevalence rate is between 5.7% and 6.2%. In Switzerland, the existing screening strategy involves routine screening of PLD who indicate they are from HCV high-risk populations based on questionnaire responses upon entry to the detention center, rather than an offer to screen all PLD.
Keywords Cost-Benefit Analysis — Hepatitis C — Mass Screening — Prisons — Antiviral Agents
Identifiers
PMID: 30715266
Full text
Article (Author postprint) (761 Kb) - public document Free access
Structures
Faculté de médecine / Section de médecine clinique / Département de médecine
Faculté de médecine / Section de médecine clinique / Département d'anesthésiologie, pharmacologie, soins intensifs et urgences
Faculté de médecine / Section de médecine fondamentale / Département de pathologie et immunologie
Faculté de médecine / Section de médecine clinique / Département de santé et médecine communautaires
Research groups Etudes et traitement de l'hépatite C et B (554)
Groupe Desmeules Jules (pharmacologie/toxicologie) (567)
Citation
(ISO format) 		GIRARDIN, François et al. Modelling the Impact and Cost-Effectiveness of Extended Screening and Treatment with Direct-Acting Antivirals in a Swiss Custodial Setting. In: Clinical Infectious Diseases, 2019. doi: 10.1093/cid/ciz088 https://archive-ouverte.unige.ch/unige:115852

142 hits

10 downloads

Contact an author

Update request

Update

Deposited on : 2019-04-08

Export document
Format :
Citation style :